Cantitate/Preț
Produs

Trends in Kidney Cancer Research

Editat de Kelvin R. Nunez
en Limba Engleză Hardback – 30 noi 2006
Kidney cancer usually occurs in older adults and constitutes about 2% of all adult cancers (more frequent in men than women). It is also known as nephrocarcinoma, renal cell carcinoma, hypernephroma, and Grawitzs tumour. This book includes within its scope the prevention, risk factors, symptoms, diagnosis, treatment, and rehabilitation of kidney cancer. Leading-edge scientific research from throughout the world is presented.
Citește tot Restrânge

Preț: 83915 lei

Preț vechi: 115164 lei
-27% Nou

Puncte Express: 1259

Preț estimativ în valută:
16057 16958$ 13363£

Carte disponibilă

Livrare economică 21 decembrie 24 - 04 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781594541414
ISBN-10: 1594541418
Pagini: 233
Ilustrații: b/w photos & tables
Dimensiuni: 189 x 259 x 21 mm
Greutate: 0.71 kg
Editura: Nova Science Publishers Inc

Cuprins

PTK787/ZK222584: A Specific VEGF-Receptor Tyrosine Kinase Inhibitor, in the Treatment of Renal Cell Carcinoma; Tumour Growth Factor-ß1 (TGF-ß1) Plasma Levels in Patients with Localised and Metastatic Renal Cell Carcinoma; Prognostic and Predictive Implications of CD8highCD57+ Lymphocytes for Advanced Renal Cell Carcinoma Patients; Thrombin Receptors in Renal Carcinoma Cells; Upper Urinary Tract Carcinoma after Intake of Aristolochia Fangchi: Value of Urinary Cytology in End-Stage "Chinese-Herb Nephropathy"; Nephrectomy and Resection of the Liver with the Inferior Vena Cava for Recurrences of Adrenal Cortical Carcinoma over Ten Years after the Adrenalectomy: Report of a 14-year-survived Case with Good Quality of Life; Quality of Life of Metastatic Renal Carcinoma Patients Receiving Subcutaneous Interferon or Intravenous Interleukin-2; Implementation of a Web-Based Clinical Pathway for Radical Nephrectomy to Improve Health Outcomes; Surgical Management of Renal Cell Carcinoma with Inferior Vena Cava Tumour Thrombus and Review of the Literature; A Critical Review: A New Trial to Overcome the Multi-drug Resistance of Renal Cell Carcinoma: From Theoretical Possibility to Therapeutic Benefit?; Surviving as Indicator of Diagnosis and Progression in Transitional Cell Carcinoma.